Allergan and Editas to assess in-vivo CRISPR editing to treat LCA10

LCA10 is an inherited retinal disorder that results in blindness. Credit: Kalea Jerielle on Unsplash.



  • Allergan and Editas Medicine in-vivo CRISPR editing study